Cell and Gene Therapy Summit

Venue: Brussels, Belgium.

Start: Monday 24 Apr 2023 09:00

End: Tuesday 25 Apr 2023 17:00

Under the stewardship of The Economist editors, this inaugural event on cell and gene therapies convenes industry stakeholders to accelerate access to transformative products.

Cell and gene therapies are redefining the treatment of many diseases, giving hope to patients who previously had no therapeutic options. These treatments can be transformative in the battle against cancer, genetic disorders and rare diseases. In the UK, NICE expects to review 30 new cell and gene therapy products by 2023, with the FDA in the US predicting between 15 and 20 new products will be on the market by 2025. Attendees will learn how healthcare systems and policies need to evolve before these therapies can become mainstream.

Through a series of interactive sessions, industry stakeholders will debate the challenges of bringing these therapies to market—including manufacturing, real-world data collection and their commercial sustainability. This conference programme examines the potential for a healthcare paradigm shift, as public opinion and patient experience evolve. The summit will also assess the innovations needed in pricing policies and payments to combat “big sticker” price tags—some products are $2.48 million per dose—and how they limit accessibility.

Speakers include:

  1. Henny Braund, chief executive, Anthony Nolan
  2. Steven Pearson, founder and president, Institute for Clinical and Economic Review
  3. Natasha Loder, health editor, The Economist
  4. Hugues Malonne, general-director pre-authorisation, Belgian Federal Agency for Medicines & Health Products
  5. Declan Noone, president, European Haemophilia Consortium
  6. Patrick Celis, scientific lead, Committee for Advanced Therapies (CAT), ATMP Office, European Medicines Agency
  7. Claire Booth, professor of gene therapy and paediatric immunology, UCL GOSH Institute of Child Health
  8. Len Valentino, president and chief executive, National Hemophilia Foundation (remote)
  9. Alexander Natz, secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
  10. Michele Salter, chair, Sickle Cell Society

Register here.